Skip to main content
Erschienen in: Techniques in Coloproctology 3/2011

01.09.2011 | Original Article

Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection

verfasst von: R. Greenberg, R. Itah, R. Ghinea, E. Sacham-Shmueli, R. Inbar, S. Avital

Erschienen in: Techniques in Coloproctology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Lymph node ratio (LNR: the ratio of metastatic to total retrieved nodes) has shown prognostic significance in several tumors. Its role in patients with colorectal cancer submitted to laparoscopic resection is still not clearly defined. The aim of this study was to evaluate the impact of LNR on long-term outcome in patients undergoing curative laparoscopic resection.

Methods

Patients’ data were retrieved from our prospective in-hospital collected data of patients that underwent laparoscopic surgery for curable colorectal cancer over a 6-year period. Long-term data were collected from our outpatient’s clinic data and personal contact when necessary.

Results

Two hundred and five patients underwent laparoscopic resection for curable colorectal cancer in the study period. Sixty-five patients were node positive. Receiver operating characteristic (ROC) analysis selected 0.13 as the best LNR cutoff value in this group. Kaplan–Meier 5-year survival analysis revealed a significant decrease in overall and disease-free survival in patients with an LNR above 0.13. Long-term outcome of patients with an LNR below 0.13 was similar to node-negative stage II patients.

Conclusions

The lymph node ratio is a valuable prognostic factor in node-positive colon cancer patients undergoing laparoscopic resection. Patients with an LNR below 0.13 have the same long-term outcome as stage II node-negative patients. The laparoscopic approach presents the same trends in terms of overall survival and disease-free survival as conventional open access when LNR is considered.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009 CA. Cancer J Clin 59:225–249CrossRef Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009 CA. Cancer J Clin 59:225–249CrossRef
2.
Zurück zum Zitat Samantas E, Dervenis C, Rigatos SK (2007) Adjuvant chemotherapy for colon cancer: evidence on improvement in survival. Dig Dis 25:67–75PubMedCrossRef Samantas E, Dervenis C, Rigatos SK (2007) Adjuvant chemotherapy for colon cancer: evidence on improvement in survival. Dig Dis 25:67–75PubMedCrossRef
3.
Zurück zum Zitat Ratto C, Sofo L, Ippoliti M et al (1999) Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 42:143–154PubMedCrossRef Ratto C, Sofo L, Ippoliti M et al (1999) Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 42:143–154PubMedCrossRef
4.
Zurück zum Zitat Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMedCrossRef Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMedCrossRef
5.
Zurück zum Zitat Ostadi MA, Harnish JL, Stegienko S, Urbach DR (2007) Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 21:2142–2146PubMedCrossRef Ostadi MA, Harnish JL, Stegienko S, Urbach DR (2007) Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc 21:2142–2146PubMedCrossRef
6.
Zurück zum Zitat Berger AC, Sigurdson ER, LeVoyer T et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712PubMedCrossRef Berger AC, Sigurdson ER, LeVoyer T et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712PubMedCrossRef
7.
Zurück zum Zitat Lee HY, Choi HJ, Park KJ et al (2007) Prognostic significance of metastatic lymph node ratio in node- positive colon carcinoma. Ann Surg Oncol 14:1712–1717PubMedCrossRef Lee HY, Choi HJ, Park KJ et al (2007) Prognostic significance of metastatic lymph node ratio in node- positive colon carcinoma. Ann Surg Oncol 14:1712–1717PubMedCrossRef
8.
Zurück zum Zitat El-Gazzaz G, Hull T, Hammel J, Geisler D (2010) Does a laparoscopic approach affect the number of lymph nodes harvested during curative surgery for colorectal cancer? Surg Endosc 24:113–118PubMedCrossRef El-Gazzaz G, Hull T, Hammel J, Geisler D (2010) Does a laparoscopic approach affect the number of lymph nodes harvested during curative surgery for colorectal cancer? Surg Endosc 24:113–118PubMedCrossRef
10.
Zurück zum Zitat Tang R, Wang JY, Chen JS et al (1995) Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Coll Surg 180:705–712 Tang R, Wang JY, Chen JS et al (1995) Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Coll Surg 180:705–712
11.
Zurück zum Zitat Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441PubMedCrossRef Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433–441PubMedCrossRef
12.
Zurück zum Zitat Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71PubMedCrossRef Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65–71PubMedCrossRef
13.
Zurück zum Zitat Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978PubMedCrossRef Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978PubMedCrossRef
14.
Zurück zum Zitat Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH (2009) Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 24:1297–1302PubMedCrossRef Chin CC, Wang JY, Yeh CY, Kuo YH, Huang WS, Yeh CH (2009) Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 24:1297–1302PubMedCrossRef
15.
Zurück zum Zitat Galizia G, Orditura M, Ferraraccio F et al (2009) The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. World J Surg 33:2704–2713PubMedCrossRef Galizia G, Orditura M, Ferraraccio F et al (2009) The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. World J Surg 33:2704–2713PubMedCrossRef
16.
Zurück zum Zitat Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600–1608PubMedCrossRef Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600–1608PubMedCrossRef
17.
Zurück zum Zitat Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34PubMedCrossRef Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34PubMedCrossRef
18.
Zurück zum Zitat Megale Costa LJ, Soares HP, Gaspar HA et al (2004) Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 27:304–306PubMedCrossRef Megale Costa LJ, Soares HP, Gaspar HA et al (2004) Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 27:304–306PubMedCrossRef
19.
Zurück zum Zitat Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240PubMed Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240PubMed
20.
Zurück zum Zitat Haboubi NY, Clark P, Kaftan SM, Schofield PF (1992) The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85:386–388PubMed Haboubi NY, Clark P, Kaftan SM, Schofield PF (1992) The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85:386–388PubMed
21.
Zurück zum Zitat Palma RT, Waisberg J, Bromberg SH, Simão AB, Godoy AC (2003) Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis 5:164–168PubMedCrossRef Palma RT, Waisberg J, Bromberg SH, Simão AB, Godoy AC (2003) Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis 5:164–168PubMedCrossRef
22.
Zurück zum Zitat Fleshman J, Sargent DJ, Green E, The Clinical Outcomes of Surgical Therapy Study Group et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 246:655–662PubMedCrossRef Fleshman J, Sargent DJ, Green E, The Clinical Outcomes of Surgical Therapy Study Group et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 246:655–662PubMedCrossRef
23.
Zurück zum Zitat Jayne DG, Guillou PJ, Thorpe H, UK MRC CLASICC Trial Group et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061–3068PubMedCrossRef Jayne DG, Guillou PJ, Thorpe H, UK MRC CLASICC Trial Group et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25:3061–3068PubMedCrossRef
24.
Zurück zum Zitat Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7PubMedCrossRef Lacy AM, Delgado S, Castells A et al (2008) The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer. Ann Surg 248:1–7PubMedCrossRef
25.
Zurück zum Zitat Nelson H, Petrelli N, Carlin A, National Cancer Institute Expert Panel et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596PubMedCrossRef Nelson H, Petrelli N, Carlin A, National Cancer Institute Expert Panel et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596PubMedCrossRef
26.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Stewart AK et al (2008) Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 100:1310–1317PubMedCrossRef Bilimoria KY, Bentrem DJ, Stewart AK et al (2008) Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst 100:1310–1317PubMedCrossRef
27.
Zurück zum Zitat Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA (2009) Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol 13:113–121PubMedCrossRef Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA (2009) Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol 13:113–121PubMedCrossRef
Metadaten
Titel
Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection
verfasst von
R. Greenberg
R. Itah
R. Ghinea
E. Sacham-Shmueli
R. Inbar
S. Avital
Publikationsdatum
01.09.2011
Verlag
Springer Milan
Erschienen in
Techniques in Coloproctology / Ausgabe 3/2011
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-011-0701-9

Weitere Artikel der Ausgabe 3/2011

Techniques in Coloproctology 3/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.